PTC Therapeutics Inc PTCT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
32.10quote price arrow down-0.15 (-0.47%)
Volume
27,612
Close
32.25quote price arrow up+1.20 (+3.86%)
Volume
563,071
52 week range
17.53 - 59.84
Loading...
  • Open31.23
  • Day High32.69
  • Day Low31.01
  • Prev Close31.05
  • 52 Week High59.84
  • 52 Week High Date05/22/23
  • 52 Week Low17.53
  • 52 Week Low Date11/02/23

Key Stats

  • Market Cap2.473B
  • Shares Out76.70M
  • 10 Day Average Volume1.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.67
  • YTD % Change17.02

KEY STATS

  • Open31.23
  • Day High32.69
  • Day Low31.01
  • Prev Close31.05
  • 52 Week High59.84
  • 52 Week High Date05/22/23
  • 52 Week Low17.53
  • 52 Week Low Date11/02/23
  • Market Cap2.473B
  • Shares Out76.70M
  • 10 Day Average Volume1.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.67
  • YTD % Change17.02

RATIOS/PROFITABILITY

  • EPS (TTM)-7.69
  • P/E (TTM)-4.20
  • Fwd P/E (NTM)-5.41
  • EBITDA (TTM)132.42M
  • ROE (TTM)-7,740.12%
  • Revenue (TTM)927.558M
  • Gross Margin (TTM)92.88%
  • Net Margin (TTM)-62.45%
  • Debt To Equity (MRQ)-239.50%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On PTC Therapeutics Inc

 

Profile

MORE
PTC Therapeutics, Inc. is a global biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The Company has a diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments...
Michael Schmertzler
Independent Chairman of the Board
Matthew Klein M.D.
President, Chief Executive Officer, Director
Neil Almstead Ph.D.
Chief Technical Operations Officer
Pierre Gravier
Chief Financial Officer
Mark Boulding
Executive Vice President, Chief Legal Officer
Address
500 Warren Corporate Center Drive
Warren, NJ
07059
United States

Top Peers

SYMBOLLASTCHG%CHG
ACAD
ACADIA Pharmaceuticals Inc
15.25+0.04+0.26%
GLPG
Galapagos NV
28.55-0.22-0.76%
MYGN
Myriad Genetics Inc
25.47+0.22+0.87%
GH
Guardant Health Inc
22.37+2.93+15.07%
NVAX
Novavax Inc
8.88+4.41+98.66%